Evidence map›Paper›PMID 28337259›Full record

ArticleAmerican journal of translational research2017

Intranasal basic fibroblast growth factor attenuates endoplasmic reticulum stress and brain injury in neonatal hypoxic-ischaemic injury.

Zhenlang Lin, Yingying Hu, Zhouguang Wang, Shulin Pan, Hao Zhang, Libing Ye, Hongyu Zhang, Mingchu Fang, Huai Jiang, Junming Ye and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Zhenlang LinDepartment of Neonatology, The First Affiliated Hospital of Xi'an Jiaotong UniversityXi'an 710061, Shaanxi, China; Department of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical UniversityWenzhou 325027, Zhejiang, China.
Yingying HuDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University Wenzhou 325027, Zhejiang, China.
Zhouguang WangMolecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
Shulin PanDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University Wenzhou 325027, Zhejiang, China.
Hao ZhangDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University Wenzhou 325027, Zhejiang, China.
Libing YeMolecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
Hongyu ZhangMolecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
Mingchu FangDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University Wenzhou 325027, Zhejiang, China.
Huai JiangDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University Wenzhou 325027, Zhejiang, China.
Junming YeDepartment of Anesthesia, The First Affiliated Hospital, Gannan Medical College Ganzhou, 341000, China.
Jian XiaoMolecular Pharmacology Research Center, School of Pharmacy, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
Li LiuDepartment of Neonatology, The First Affiliated Hospital of Xi'an Jiaotong University Xi'an 710061, Shaanxi, China.
Wenzhou Medical University · CNFirst Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain injury secondary to birth asphyxia is the major cause of death and long-term disability in newborns. Intranasal drug administration enables agents to bypass the blood-brain barrier (BBB) and enter the brain directly. In this study, we determined whether intranasal basic fibroblast growth factor (bFGF) could exert neuroprotective effects in neonatal rats after hypoxic-ischaemic (HI) brain injury and assessed whether attenuation of endoplasmic reticulum (ER) stress was associated with these neuroprotective effects. Rats were subjected to HI brain injury via unilateral carotid artery ligation followed by 2.5 h of hypoxia and then treated with intranasal bFGF or vehicle immediately after HI injury. We found that the unfolded protein response (UPR) was strongly activated after HI injury and that bFGF significantly reduced the levels of the ER stress signalling proteins GRP78 and PDI. bFGF also decreased brain infarction volumes and conferred long-term neuroprotective effects against brain atrophy and neuron loss after HI brain injury. Taken together, our results suggest that intranasal bFGF provides neuroprotection function partly by inhibiting HI injury-induced ER stress. bFGF may have potential as a therapy for human neonates after birth asphyxia.

Indexed as

bFGFER stresshypoxic-ischaemia brain injuryneuroprotection

Identifiers

PMID28337259
PMCPMC5340666
OpenAlexW2977408589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.